A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Clinical trial NCT01413178 · COMPLETED
Trial details
- NCT number
- NCT01413178
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-30
- Primary completion
- 2019-03-10
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.